Funder: European Commission
Due Dates: October 9, 2025 (Short proposal, stage 1) | April 29, 2026 (Full proposal, stage 2)
Funding Amounts: Up to €8,906,000 from IHI JU; total project value with industry in-kind ~€20.3M; project duration up to 60 months.
Summary: Funds AI-driven research to improve signal detection and risk prediction in pharmacovigilance, aiming for faster, more accurate drug safety monitoring using diverse data sources.
Key Information: UK and Canadian participants are not eligible for funding; 45% industry/contributing partner contribution required at full proposal stage.